FMC

Fmc Corp Materials Chemicals & Allied Products Russell 3000
$6.20Close $774.6MMarket cap $4.47 – $17.9452-week range Jan 28, 2027Next report · estimated

Highlights

Cautions

  • Not in an uptrend 1 of 8 trend conditions
  • Lagging the market RS 1 · weaker than 99% of stocks over 12 months
  • Far from its high 65% below its 52-week high
  • Distribution down-day volume 1.8× up-day volume over 50 sessions
  • Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 30, 2026
Off 12-month high 65%
1wk up 22.8% price change
1mo down 30.5% price change
12-month return down 59% market up 11% · its own down 89%
F-score 3 / 9 Weak
Altman Z 0.62 Elevated risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 0.4× price / book
Earnings yield down 55.0% EBIT / enterprise value
Cheaper than 35% of the market · expensive
Revenue growth down 18% year on year
EPS growth — latest quarter
Sales growth down 80% latest quarter · -63 pts
ROE down 68% return on equity
Free cash margin down 3% -$102.5M FCF
D/E 1.34 long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • operating cash flow is negative
  • profitability slipped from last year
  • short-term liquidity weakened
  • gross margin narrowed
  • assets working less efficiently
  • profits backed by cash
  • reduced long-term debt
  • no new shares issued

Repair signals

  • Long-term debt down 9% ($3.0B → $2.8B)

Trade setup

ATR% 9.8% $0.61 a day · 2×ATR $4.98
RS 1 / 99 vs the universe
Trend 1 / 8 trend template
Relative volume 3.2× vs 50-day average
Up/down volume 0.57 50 sessions
Implied move — no scheduled report
Trend template · 1 of 8
  • At least 30% above the 52-week low: passes

Screen verdict

Did not qualify for any screen.

Warning signs

4 flagged
  • Material impairment The company disclosed a material impairment - an asset written down below the value the balance sheet had been carrying.
  • Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
  • Gross margin narrowing Gross margin fell from 38.8% to 37.0%. The company is keeping less of each dollar of sales than it did a year ago.
  • Revenue shrinking Revenue fell 18.3% over the year, from $4.2B to $3.5B.
Last reported Oct 29, 2026
Last shock Oct 15, 2026-31% in one session7.7× volumeon results+10% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $3.5B -18% on FY2024
$0 $10B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $4.6B FY2021 · $5.0B FY2022 · $5.8B FY2023 · $4.5B FY2024 · $4.2B FY2025 · $3.5B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$2.2B down to a loss
-$2.5B $0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $552.4M FY2021 · $739.6M FY2022 · $736.5M FY2023 · $1.3B FY2024 · $341.1M FY2025 · -$2.2B
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology -$102.5M down to a loss
-$500M $0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $669.6M FY2021 · $798.5M FY2022 · $517.7M FY2023 · -$434.2M FY2024 · $668.8M FY2025 · -$102.5M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 37%
  • Net -65%
  • Free cash -3%
-100% 0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 44% · Net 12% · Free cash 14% FY2021 · Gross 43% · Net 15% · Free cash 16% FY2022 · Gross 40% · Net 13% · Free cash 9% FY2023 · Gross 41% · Net 29% · Free cash -10% FY2024 · Gross 39% · Net 8% · Free cash 16% FY2025 · Gross 37% · Net -65% · Free cash -3%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $2.2B net debt
  • Cash
  • Long-term debt
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $568.9M · Long-term debt $2.9B FY2021 · Cash $516.8M · Long-term debt $2.7B FY2022 · Cash $572.0M · Long-term debt $2.7B FY2023 · Cash $302.4M · Long-term debt $3.0B FY2024 · Cash $357.3M · Long-term debt $3.0B FY2025 · Cash $584.5M · Long-term debt $2.8B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 124.93m -3.4% since FY2020
129.35m 124.76m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 129.35m FY2021 · 125.70m FY2022 · 125.11m FY2023 · 124.76m FY2024 · 124.84m FY2025 · 124.93m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $4.6B $5.0B $5.8B $4.5B $4.2B $3.5B
Gross margin 44% 43% 40% 41% 39% 37%
Operating income $896.9M $1.0B $1.1B $555.6M $506.5M -$1.6B
Net income $552.4M $739.6M $736.5M $1.3B $341.1M -$2.2B
Net margin 12% 15% 13% 29% 8% -65%
Earnings per share $4.23 $5.73 $5.81 $10.53 $2.72 -$17.89
Free cash flow $669.6M $798.5M $517.7M -$434.2M $668.8M -$102.5M
Free cash margin 14% 16% 9% -10% 16% -3%
Cash $568.9M $516.8M $572.0M $302.4M $357.3M $584.5M
Long-term debt $2.9B $2.7B $2.7B $3.0B $3.0B $2.8B
Shareholders' equity $3.0B $3.1B $3.4B $4.4B $4.5B $2.1B
Shares outstanding 129.35m 125.70m 125.11m 124.76m 124.84m 124.93m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 30, 2026 Quarterly ↗ Sep 30, 2026 30d
Jul 30, 2026 Quarterly ↗ Jun 30, 2026 30d
Apr 30, 2026 Quarterly ↗ Mar 31, 2026 30d
Feb 27, 2026 Annual ↗ Dec 31, 2025 58d
Oct 30, 2025 Quarterly ↗ Sep 30, 2025 30d
Jul 31, 2025 Quarterly ↗ Jun 30, 2025 31d
May 1, 2025 Quarterly ↗ Mar 31, 2025 31d
Feb 28, 2025 Annual ↗ Dec 31, 2024 59d
Oct 30, 2024 Quarterly ↗ Sep 30, 2024 30d
Aug 1, 2024 Quarterly ↗ Jun 30, 2024 32d
May 7, 2024 Quarterly ↗ Mar 31, 2024 37d
Feb 27, 2024 Annual ↗ Dec 31, 2023 58d

Current reports